ArticleFrontiers in pharmacology2019

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study.

Giovanna Elisiana Carpagnano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.